UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 143

Sortiert nach

Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5542-5551

2005

Volltextzugriff (PDF)

Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study

Journal of clinical oncology, 1998-03, Vol.16 (3), p.994-999

1998

Volltextzugriff (PDF)

Phase I Trial of Exisulind (Sulindac Sulfone, FGN-1) as a Chemopreventive Agent in Patients with Familial Adenomatous Polyposis

Clinical cancer research, 2000-01, Vol.6 (1), p.78-89

2000

Volltextzugriff (PDF)

Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumors

Cancer, 1997-09, Vol.80 (6), p.1134-1140

1997

Volltextzugriff (PDF)

Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706

Leukemia, 2005-11, Vol.19 (11), p.1880-1886

2005

Volltextzugriff (PDF)

Phase II trial of liposomal doxorubicin (Doxil®) in advanced soft tissue sarcomas

Investigational new drugs, 2000-08, Vol.18 (3), p.253-259

2000

Volltextzugriff (PDF)

A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinoma

Investigational new drugs, 2002-08, Vol.20 (3), p.305-310

2002

Volltextzugriff (PDF)

Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma

Journal of cancer research and clinical oncology, 2001-05, Vol.127 (5), p.319-324

2001

Volltextzugriff (PDF)

Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study

Journal of clinical oncology, 1995-04, Vol.13 (4), p.831-839

1995

Volltextzugriff (PDF)

Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma

Cancer research (Chicago, Ill.), 1991-08, Vol.51 (16), p.4199-4205

1991

Volltextzugriff (PDF)

Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial

Journal of clinical oncology, 1988-05, Vol.6 (5), p.880-888

1988

Volltextzugriff (PDF)

Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial

Journal of clinical oncology, 1997-07, Vol.15 (7), p.2494-2501

1997

Volltextzugriff (PDF)

Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancy

Journal of clinical oncology, 1992-05, Vol.10 (5), p.804-809

1992

Volltextzugriff (PDF)

Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects

Journal of clinical oncology, 1994-01, Vol.12 (1), p.97-106

1994

Volltextzugriff (PDF)

Palliative chemotherapy of adult soft tissue sarcomas

Seminars in oncology, 1995-04, Vol.22 (2), p.30-34

BUDD, G. T

1995

Volltextzugriff (PDF)

Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancer

Journal of cancer research and clinical oncology, 1999-08, Vol.125 (8-9), p.500-504

1999

Volltextzugriff (PDF)

Delivering adjuvant chemotherapy to women with early-stage breast carcinoma : Current patterns of care

Cancer, 2001-09, Vol.92 (6), p.1354-1367

2001

Volltextzugriff (PDF)

Phase II trial of subcutaneously administered granulocyte‐macrophage colony‐stimulating factor in patients with metastatic renal cell carcinoma

Cancer, 1996-03, Vol.77 (6), p.1149-1153

1996

Volltextzugriff (PDF)

Adjuvant therapy of osteosarcoma: A phase II trial: Southwest oncology group study 9139

Cancer, 2004-02, Vol.100 (4), p.818-825

2004

Volltextzugriff (PDF)

Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings

Clinical cancer research, 1996-02, Vol.2 (2), p.347-357

1996

Volltextzugriff (PDF)

A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer

Cancer chemotherapy and pharmacology, 2000, Vol.46 (3), p.251-254

2000

Volltextzugriff (PDF)

Breast Tumor Immunophenotype of BRCA1-Mutation Carriers Is Influenced by Age at Diagnosis

Clinical cancer research, 2001-07, Vol.7 (7), p.1937-1945

2001

Volltextzugriff (PDF)

Phase I trial of dipyridamole with 5-fluorouracil and folinic acid

Cancer research (Chicago, Ill.), 1990-11, Vol.50 (22), p.7206-7211

1990

Volltextzugriff (PDF)

Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancy

Journal of immunotherapy with emphasis on tumor immunology, 1996-01, Vol.19 (1), p.69

1996

Volltextzugriff (PDF)

Phase I study of WR-2721 and carboplatin

European journal of cancer (1990), 1993, Vol.29 (8), p.1122-1127

1993

Volltextzugriff (PDF)

1 – 25 von 143

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(120)

Publikationsform

Artikel
(143)

Sprache

Englisch
(143)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Humans
(143)
Science & Technology
(118)
Life Sciences & Biomedicine
(116)
Female
(114)
Middle Aged
(108)
Male
(86)
Aged
(84)
Oncology
(69)
Biological And Medical Sciences
(62)
Medical Sciences
(58)
Pharmacology. Drug Treatments
(36)
Antineoplastic Agents
(33)
Aged, 80 And Over
(29)
Chemotherapy
(28)
Breast Neoplasms - Drug Therapy
(26)
Breast Neoplasms - Pathology
(22)
Treatment Outcome
(22)
Adolescent
(21)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(21)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer

Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study

Phase I Trial of Exisulind (Sulindac Sulfone, FGN-1) as a Chemopreventive Agent in Patients with Familial Adenomatous Polyposis

Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumors

Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706

Phase II trial of liposomal doxorubicin (Doxil®) in advanced soft tissue sarcomas

A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinoma

Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma

Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study

Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma

Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial

Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial

Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancy

Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects

Palliative chemotherapy of adult soft tissue sarcomas

Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancer

Delivering adjuvant chemotherapy to women with early-stage breast carcinoma : Current patterns of care

Phase II trial of subcutaneously administered granulocyte‐macrophage colony‐stimulating factor in patients with metastatic renal cell carcinoma

Adjuvant therapy of osteosarcoma: A phase II trial: Southwest oncology group study 9139

Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings

A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer

Breast Tumor Immunophenotype of BRCA1-Mutation Carriers Is Influenced by Age at Diagnosis

Phase I trial of dipyridamole with 5-fluorouracil and folinic acid

Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancy

Phase I study of WR-2721 and carboplatin

Aktive Filter

Suchergebnisse filtern